1-5 of 5
Toshihiko Nishimura
Close
Sort by
Journal Articles

Deficiency of Either Carboxypeptidase B2 or Carboxypeptidase N Exacerbated Disease Activity in a Mouse Model of Hemolytic Uremic Syndrome

Lawrence L. Leung, MD, Zhifei Shao, MD PhD, Toshihiko Nishimura, PhD, Qin Zhou, PhD, Laura Gigliello, Peter Castro, John Higgins, John Morser, PhD
Journal: Blood
Blood (2016) 128 (22): 3758.
https://doi.org/10.1182/blood.V128.22.3758.3758
Published: 2016
Journal Articles

Carboxypeptidase B2 Is Protective in a Mouse Model of Shiga Toxin-Induced Hemolytic Uremic Syndrome

Toshihiko Nishimura, PhD, John Morser, PhD, Zhifei Shao, MD PhD, Lawrence L. Leung, MD
Journal: Blood
Blood (2014) 124 (21): 2804.
https://doi.org/10.1182/blood.V124.21.2804.2804
Published: 2014
Journal Articles

CPB2 Deficiency Protects Against Polymicrobial Sepsis

Zhifei Shao, MD, PhD, Toshihiko Nishimura, PhD, Lawrence L. Leung, MD, John Morser, PhD
Journal: Blood
Blood (2012) 120 (21): 1110.
https://doi.org/10.1182/blood.V120.21.1110.1110
Published: 2012
Journal Articles

Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo

Toshihiko Nishimura, Timothy Myles, Adrian M. Piliposky, Peter N. Kao, Gerald J. Berry, Lawrence L. K. Leung
Journal: Blood
Blood (2006) 109 (5): 1992–1997.
https://doi.org/10.1182/blood-2006-03-012567
Published: 2006
Journal Articles

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Regulates Activated Complement C5a in Vivo.

Toshihiko Nishimura, MD, Timothy Myles, PhD, Mariko Nagashima, PhD, John Morser, PhD, Ronald G. Pearl, MD, Lawrence L.K. Leung, MD
Journal: Blood
Blood (2004) 104 (11): 2973.
https://doi.org/10.1182/blood.V104.11.2973.2973
Published: 2004